* Molecular Templates Inc MTEM.OQ MTEM.O is expected
to show a
fall in quarterly revenue when it reports results on May 13
(estimated) for the period ending March 31 2024
* The Austin Texas-based company is expected to report a
83.9% decrease in revenue to $5.897 million from $36.63 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Molecular Templates Inc
is for
a loss of 78 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Molecular
Templates Inc is $16.50, above its last closing price
of $1.48.
This summary was machine generated May 11 at 00:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)